QDEL
QuidelOrthoANasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-20
Current thesis
LEX, High-Sensitivity Troponin, and VITROS 450 could improve the portfolio mix and restore growth if launches gain adoption, while Immunohematology's Q1 growth provides a partial offset to respiratory weakness.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +17.9.
What can break
Final China NHSA IVD pricing rules and implementation timing remain uncertain.
Momentum
91
Value
54
Sentiment
64
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $20.50 · Bull $25.00 · Bear $13.50
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-18 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $20.50
Why
Momentum91 · Δ7d +17.9
Value54 · Δ7d -0.0
Sentiment64 · Δ7d +1.4
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
91
26% active weight
Current posture
7d trendImproving
Δ7d
+17.9
Δ21d
+50.2
Value
54
39% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.4
Sentiment
64
34% active weight
Current posture
7d trendImproving
Δ7d
+1.4
Δ21d
-47.1
Why this grade
Composite grade A. Momentum 90.5 / Value 54.0 / Sentiment 64.2
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$1.13B
Beta
0.68
Shares Out
68.19M
P/E (TTM) · Derived
-1.0
P/S (TTM)
0.75
P/FCF (TTM)
106.34
Rev YoY
-10.7%
EPS YoY
+615.2%
Gross Margin
+38.0%
Op Margin
-35.3%
Net Debt
$2.66B
Current Ratio
1.43
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology